Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8000
-0.0500 (-5.88%)
Apr 2, 2026, 3:27 PM HKT

HKG:3737 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7372,2152,0501,8261,747
Revenue Growth (YoY)
-21.55%8.05%12.26%4.55%8.89%
Cost of Revenue
791.6933.45835.21758.59685.15
Gross Profit
945.891,2811,2151,0671,061
Selling, General & Admin
893.861,094994.81914.57932.14
Other Operating Expenses
55.4161.7255.449.2849.64
Operating Expenses
949.271,1561,050963.84981.77
Operating Income
-3.39125.14164.4103.5179.58
Interest Expense
-5.38-6.99-7.87-6.56-7.08
Interest & Investment Income
2.995.27.0244.22
Other Non Operating Income (Expenses)
20.6232.7640.1926.5824.6
EBT Excluding Unusual Items
14.84156.1203.74127.53101.32
Gain (Loss) on Sale of Investments
3.77-9.753.412.43-39.61
Gain (Loss) on Sale of Assets
0.380.550.430.690.11
Pretax Income
18.99146.9207.58130.6561.81
Income Tax Expense
1.2950.7543.4523.749.45
Earnings From Continuing Operations
17.796.15164.13106.9252.37
Minority Interest in Earnings
-0.41-0.94-1.36-0.53-0.24
Net Income
17.2995.21162.78106.3952.13
Net Income to Common
17.2995.21162.78106.3952.13
Net Income Growth
-81.84%-41.51%53.00%104.09%-62.37%
Shares Outstanding (Basic)
823845847847837
Shares Outstanding (Diluted)
823845847847837
Shares Change (YoY)
-2.60%-0.18%-1.20%0.98%
EPS (Basic)
0.020.110.190.130.06
EPS (Diluted)
0.020.110.190.130.06
EPS Growth
-80.91%-42.11%51.27%109.34%-64.10%
Free Cash Flow
-40.72-67.68196.17-7.47
Free Cash Flow Per Share
-0.05-0.080.23-0.01
Dividend Per Share
-0.0470.0820.053-
Dividend Growth
--42.49%53.92%--
Gross Margin
54.44%57.85%59.25%58.45%60.77%
Operating Margin
-0.19%5.65%8.02%5.67%4.56%
Profit Margin
1.00%4.30%7.94%5.83%2.99%
Free Cash Flow Margin
-1.84%-3.30%10.74%-0.43%
EBITDA
43.8172.32215.3153.87119.71
EBITDA Margin
2.52%7.78%10.50%8.43%6.85%
D&A For EBITDA
47.1947.1950.950.3740.14
EBIT
-3.39125.14164.4103.5179.58
EBIT Margin
-0.19%5.65%8.02%5.67%4.56%
Effective Tax Rate
6.77%34.55%20.93%18.17%15.28%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.